title: Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells.
abstract: The behavior of breast epithelial cells is influenced by their microenvironment which includes stromal cells and extracellular matrix (ECM). During cancer progression, the tissue microenvironment fails to control proliferation and differentiation, resulting in uncontrolled growth and invasion. Upon invasion, the ECM encountered by breast cancer cells changes from primarily laminin and collagen IV to primarily collagen I. We show here that culturing invasive breast cancer cells in 3-dimensional (3D) collagen I inhibits proliferation through direct regulation of cyclin E1, a G(1)/S regulator that is overexpressed in breast cancer. When the breast cancer cell line MDA-MB-231 was cultured within 3D collagen I gels, the G(1)/S transition was inhibited as compared to cells cultured on conventional 2D collagen or plastic dishes. Cells in 3D collagen downregulated cyclin E1 protein and mRNA, with no change in cyclin D1 level. Cyclin D1 was primarily cytoplasmic in 3D cultures, and this was accompanied by decreased phosphorylation of Rb, a nuclear target for both cyclin E1- and cyclin D1-associated kinases. Positive regulators of cyclin E1 expression, the transcription factor c-Myc and cold-inducible RNA binding protein (CIRP), were decreased in 3D collagen cultures, while the collagen I receptor β1 integrin was greatly increased. Inhibition of β1 integrin function rescued proliferation and cyclin E1 expression as well as c-Myc expression and Rb phosphorylation, but cyclin D1 remained cytoplasmic. We conclude that cyclin E1 is repressed independent of effects on cyclin D1 in a 3D collagen environment and dependent on β1 integrin interaction with collagen I, reducing proliferation of invasive breast cancer cells.
authors.affiliation: Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center,, Albuquerque, NM 87131-0001, USA.
authors.forename: Yuehan
authors.initials: Y
authors.lastname: Wu
authors.forename: Xun
authors.initials: X
authors.lastname: Guo
authors.forename: Yekaterina
authors.initials: Y
authors.lastname: Brandt
authors.forename: Helen J
authors.initials: HJ
authors.lastname: Hathaway
authors.forename: Rebecca S
authors.initials: RS
authors.lastname: Hartley
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D003094:Collagen / Q000378:metabolism / Q000494:pharmacology*; D019938:Cyclin D1 / Q000378:metabolism; D019927:Cyclin E / Q000378:metabolism*; D003593:Cytoplasm / Q000378:metabolism; D015536:Down-Regulation / Q000187:drug effects; D005260:Female; D006801:Humans; D019012:Integrin beta1 / Q000378:metabolism*; D015513:Oncogene Proteins / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D021381:Protein Transport; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism; D016160:Retinoblastoma Protein / Q000378:metabolism
chemical_list: C475820:CCNE1 protein, human; D019927:Cyclin E; D019012:Integrin beta1; D015513:Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D016160:Retinoblastoma Protein; D019938:Cyclin D1; D003094:Collagen